NASDAQ: PRVAPrivia Health Group Inc Stock
$22.39+0.89 (+4.14%)
Updated Feb 13, 2026
PRVA Price
$22.39
Fair Value Price
$36.89
Market Cap
$2.75B
52 Week Low
$18.77
52 Week High
$26.51
P/E
149.27x
P/B
3.88x
P/S
1.5x
PEG
2.63x
Dividend Yield
N/A
Revenue
$2.04B
Earnings
$18.17M
Gross Margin
10.2%
Operating Margin
1.58%
Profit Margin
0.9%
Debt to Equity
0.83
Operating Cash Flow
$111M
Beta
1.04
Next Earnings
Mar 3, 2026
Ex-Dividend
N/A
Next Dividend
N/A
PRVA Overview
Privia Health Group, Inc. collaborates with medical groups, health plans, and health systems, providing purpose-built platforms that organize physicians into physician-led primary-care-centric networks. The Privia Platform integrates Privia-developed and third-party applications into a seamless workflow interface that manages all aspects of the provision of healthcare services. Privia Health Group was founded in 2007 and is headquartered in Arlington, VA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PRVA's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
PRVA
Ranked#27 of 45
Ranked#27 of 45
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $19.50 | A | |
| $8.75 | A | |
| $99.71 | A |
Be the first to know about important PRVA news, forecast changes, insider trades & much more!
PRVA News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PRVA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PRVA ($22.39) is undervalued by 39.3% relative to our estimate of its Fair Value price of $36.89 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
PRVA ($22.39) is significantly undervalued by 39.3% relative to our estimate of its Fair Value price of $36.89 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
PRVA ($22.39) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PRVA due diligence checks available for Premium users.
Valuation
PRVA fair value
Fair Value of PRVA stock based on Discounted Cash Flow (DCF)
Price
$22.39
Fair Value
$36.89
Undervalued by
39.30%
PRVA ($22.39) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PRVA ($22.39) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PRVA ($22.39) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PRVA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
149.27x
Industry
27.15x
Market
43.92x
PRVA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PRVA is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
PRVA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.88x
Industry
3.22x
PRVA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PRVA price to earnings growth (PEG)
For valuing profitable companies with growth potential
PRVA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
PRVA's financial health
Profit margin
Revenue
$580.4M
Net Income
$6.9M
Profit Margin
1.2%
PRVA's Earnings (EBIT) of $32.25M... subscribe to Premium to read more.
Interest Coverage Financials
PRVA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.4B
Liabilities
$588.2M
Debt to equity
0.83
PRVA's short-term assets ($970.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRVA's short-term assets ($970.93M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRVA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$52.0M
Investing
-$1.2M
Financing
$431.0k
PRVA's operating cash flow ($110.70M)... subscribe to Premium to read more.
Debt Coverage Financials
PRVA vs Health Information Service Stocks
Privia Health Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.